Home » Topics » Regulatory » Patents

Patents
RSS

Roche patents new GABRA5 PAMs

Dec. 1, 2021

CSPC Zhongqi Pharmaceutical Technology divulges tyrosine kinase receptor inhibitors

Dec. 1, 2021

New RIPK1 inhibitors presented by National Institute of Pharmaceutical R&D

Nov. 30, 2021

Eli Lilly and Company identifies CSF1R inhibitors

Nov. 30, 2021

Txinno Bioscience presents new ENPP1 inhibitors

Nov. 30, 2021

Dartmouth College discloses new GR antagonists

Nov. 30, 2021

Shanghai Longwood Biopharmaceuticals divulges PD-1/PD-L1 interaction inhibitors

Nov. 30, 2021

Bristol Myers Squibb presents Gal-3 inhibitors

Nov. 29, 2021

Takeda Pharmaceutical identifies new 5-HT4 receptor agonists

Nov. 29, 2021

Merck & Co. synthesizes new LAAO inhibitors

Nov. 29, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...